|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.94 USD | -1.53% |
|
-4.12% | -21.60% |
| Market Cap | 3.59B 3.09B 2.85B 2.67B 5.02B 339B 5.07B 33.62B 13.1B 166B 13.46B 13.17B 575B | P/E Ratio 2026 * |
54x | P/E Ratio 2027 * | 29.1x |
|---|---|---|---|---|---|
| Enterprise Value | 2.62B 2.26B 2.08B 1.95B 3.66B 248B 3.7B 24.56B 9.57B 121B 9.83B 9.62B 420B | EV / Sales 2026 * |
2.11x | EV / Sales 2027 * | 1.65x |
| Free-Float |
99.68% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: ACADIA Pharmaceuticals Inc.
| 1 day | -1.53% | ||
| 1 week | -4.12% | ||
| Current month | -3.32% | ||
| 1 month | -2.15% | ||
| 3 months | -2.10% | ||
| 6 months | -21.87% | ||
| Current year | -21.60% |
| 1 week | 20.84 |  | 21.68 |
| 1 month | 20.3 | | 22.14 |
| Current year | 19.89 | | 27.81 |
| 1 year | 19.69 | | 28.35 |
| 3 years | 13.4 | | 33.99 |
| 5 years | 12.24 | | 33.99 |
| 10 years | 12.24 | | 58.72 |
| Manager | Title | Age | Since |
|---|---|---|---|
Catherine Adams
CEO | Chief Executive Officer | 55 | 2024-09-19 |
Mark Schneyer
DFI | Director of Finance/CFO | 52 | 2021-09-09 |
Scott Cenci
CTO | Chief Tech/Sci/R&D Officer | - | 2025-08-03 |
| Director | Title | Age | Since |
|---|---|---|---|
Laura Brege
BRD | Director/Board Member | 68 | 2008-04-30 |
Stephen Biggar
CHM | Chairman | 55 | 2016-06-09 |
Edmund Harrigan
BRD | Director/Board Member | 73 | 2015-11-24 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 05-28 | Fiscal year | Director | 41,529 | 0.0243% | ||
| 05-28 | Fiscal year | Director | 41,529 | 0.0243% | ||
| 05-28 | Fiscal year | Director | 29,335 | 0.0171% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.53% | -4.12% | -5.42% | -13.00% | 3.59B | |
| -0.12% | -0.18% | -12.80% | -12.90% | 43.51B | |
| -2.17% | +4.70% | +293.71% | +535.99% | 33.29B | |
| -1.60% | -1.58% | -0.19% | +31.82% | 29.34B | |
| +0.44% | -3.80% | +12.51% | -17.06% | 29.9B | |
| -0.29% | +2.65% | +13.24% | +21.04% | 25.42B | |
| +3.54% | +8.43% | - | - | 14.36B | |
| -1.26% | -1.11% | +53.37% | +108.10% | 13.18B | |
| -1.04% | -3.48% | +2.42% | +1.98% | 12.72B | |
| -1.18% | -2.00% | +107.41% | +78.18% | 12.08B | |
| Average | -0.52% | +0.67% | +51.58% | +81.57% | 21.74B | |
| Weighted average by Cap. | -0.54% | +1.15% | +58.80% | +101.40% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.24B 1.07B 985M 925M 1.74B 117B 1.75B 11.64B 4.53B 57.46B 4.66B 4.56B 199B | 1.39B 1.2B 1.1B 1.03B 1.94B 131B 1.96B 13.02B 5.07B 64.29B 5.21B 5.1B 223B |
| Net income | 66.5M 57.31M 52.77M 49.55M 93.03M 6.29B 94.01M 624M 243M 3.08B 250M 244M 10.67B | 131M 113M 104M 97.55M 183M 12.38B 185M 1.23B 478M 6.06B 491M 481M 21.01B |
| Net Debt | -967M -833M -767M -720M -1.35B -91.41B -1.37B -9.07B -3.53B -44.76B -3.63B -3.55B -155B | -1.29B -1.11B -1.03B -964M -1.81B -122B -1.83B -12.13B -4.72B -59.87B -4.85B -4.75B -207B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-16 | 20.94 $ | -1.53% | 1,242,241 |
| 26-06-15 | 21.26 $ | +0.83% | 1,209,891 |
| 26-06-12 | 21.09 $ | -1.40% | 753,938 |
| 26-06-11 | 21.39 $ | +0.66% | 945,147 |
| 26-06-10 | 21.25 $ | -2.70% | 1,231,797 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ACAD Stock
Select your edition
All financial news and data tailored to specific country editions
